论文部分内容阅读
目的观察静脉应用人血丙种球蛋白治疗婴幼儿重症肺炎的疗效。方法将患儿随机分成两组。两组病例均给予综合治疗，治疗组在此基础上加用人血丙种球蛋白。结果并发症的纠正治疗组明显优于对照组，总病程前者１０．９±２．３ｄ，后者１４．８±４．５ｄ，前者比后者明显缩短（ｔ＝６．６７，Ｐ＜０．０１）；病死率前者为１．３％，后者为６．２％，前者低于后者，但差异无显著性（Ｐ＝０．１１）。结论静脉滴注人血丙种球蛋白治疗婴幼儿重症肺炎，可及时纠正其并发症，缩短病程。
Objective To observe the therapeutic effect of intravenous administration of human gamma globulin on infants with severe pneumonia. Methods The children were randomly divided into two groups. Two groups of patients were given comprehensive treatment, the treatment group on the basis of the addition of human blood gamma globulin. Results Correction of treatment group was significantly better than the control group, the total duration of the former was 10.9 ± 2.3d, the latter 14.8 ± 4.5d, the former was significantly shorter than the latter (t = 6.67, P <0 .01). The former was 1.3% and the latter was 6.2%. The former was lower than the latter, but the difference was not significant (P = 0.11). Conclusion Intravenous infusion of human blood gamma globulin for the treatment of severe pneumonia in infants and young children can promptly correct its complications and shorten the course of the disease.